- United States
- /
- Machinery
- /
- NasdaqGM:PDYN
Palladyne AI Second Quarter 2025 Earnings: Revenues Disappoint
Palladyne AI (NASDAQ:PDYN) Second Quarter 2025 Results
Key Financial Results
- Net loss: US$7.49m (loss widened by 41% from 2Q 2024).
- US$0.20 loss per share.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Palladyne AI Earnings Insights
Looking ahead, revenue is forecast to grow 81% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Machinery industry in the US.
Performance of the American Machinery industry.
The company's shares are down 8.7% from a week ago.
Risk Analysis
Before you take the next step you should know about the 4 warning signs for Palladyne AI (2 are a bit unpleasant!) that we have uncovered.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGM:PDYN
Palladyne AI
A technology company, develops and offers embodied artificial intelligence software and collaborative autonomy solutions in the United States.
Flawless balance sheet with slight risk.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Adobe: A Probabilistic Case for Undervaluation

A Capital Allocation Favorite with Structural Importance

Good foundation, but now it's all about the next steps
Recently Updated Narratives

LSIP's Fortunes Will Spike with a 39.68% Revenue Surge

Adobe: A Probabilistic Case for Undervaluation

Near zero debt, Japan centric focus provides future growth
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

